Insider · CIK 0001764707
McClure Kathleen R
cfoofficer
Files at ACN (Accenture plc). First filing Oct 18, 2024, latest Oct 18, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.9M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 47Moderate | sell 810b5-1 | ACN Accenture plc | $1.9M | 5,090 | -12% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | ACN Accenture plc | AGrant or award Class A ordinary shares | +55 | $0.00 | $0 | 38,960 | Nov 19, 2024 |
| Nov 15, 2024 | ACN Accenture plc | FTax withholding Class A ordinary shares | -22 | $354.38 | $7,796 | 38,938 | Nov 19, 2024 |
| Nov 5, 2024 | ACN Accenture plc | AGrant or award Class A ordinary shares | +80 | $344.81 | $28k | 38,905 | Nov 6, 2024 |
| Oct 17, 2024 | ACN Accenture plc | SOpen-market sale Class A ordinary shares10b5-1 | -1,140 | $372.45 | $425k | 42,775 | Oct 18, 2024 |
| Oct 17, 2024 | ACN Accenture plc | SOpen-market sale Class A ordinary shares10b5-1 | -3,794 | $373.42 | $1.4M | 38,981 | Oct 18, 2024 |
| Oct 17, 2024 | ACN Accenture plc | SOpen-market sale Class A ordinary shares10b5-1 | -156 | $374.06 | $58k | 38,825 | Oct 18, 2024 |
| Oct 15, 2024 | ACN Accenture plc | AGrant or award Class A ordinary shares | +10,201 | $0.00 | $0 | 49,026 | Oct 16, 2024 |
| Oct 15, 2024 | ACN Accenture plc | FTax withholding Class A ordinary shares | -5,111 | $368.22 | $1.9M | 43,915 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.